Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker ; volume:24 ; number:1 ; day:9 ; month:8 ; year:2024 ; pages:1-18 ; date:12.2024
BMC cancer ; 24, Heft 1 (9.8.2024), 1-18, 12.2024
- Urheber
-
Zhang, Dongxu
Liang, Pu
Xia, Bowen
Wu, Jitao
Hu, Xiaopeng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-024-12703-x
- URN
-
urn:nbn:de:101:1-2410291014454.666272604226
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Dongxu
- Liang, Pu
- Xia, Bowen
- Wu, Jitao
- Hu, Xiaopeng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker
Author Correction: SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker
Author Correction: SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker
Author Correction: SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer